California biotech CEOs want: more money; less FDA regulation
Preview of annual PwC survey finds that disease foundations and NGOs are a growing part of biotech investment
IMS Health/SDI integration is essentially approved by FTC; Thomson Reuters reassesses divestiture
More reshuffling of healthcare-analytics market is in store
The global distribution perspective
Rapidly rising healthcare-products trade is almost being matched by increased regulatory scrutiny
Industry collaborates on logistics and supply chain security
With Rx-360 already at critical mass and delivering results, the call is out for more participation
A Conversation with Meghan Fitzgerald, President, Cardinal Health Specialty Solutions
Aggregate Spending Rules Arrive, But Industry Is Still Gearing Up
The 'Sunshine Act' provisions of the Affordable Care Act require records to be kept beginning Jan. 1
Battle lines draw up between PBMs and manufacturers who use copay coupons
PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons 'lure consumers to switch from generics to expensive brands'
The R&D Decline Is Worse Than Thought, Says Oliver Wyman
White paper points out the drop in pipeline performance; suggests a new direction is necessary
Brand Owner-CMO Collaboration Is Growing--But Is Far From Mature
The long-recommended practice of shared data and plans between biopharma companies and their contract manufacturing organizations (CMOs) is beginning to take hold
Understanding Class of Trade Concepts
‘Class of Trade’ is a murky element of contracts and channel analytics that can have important legal implications
Generics Manufacturers Grapple With Tight Economics
But the global picture is sunny as most of the global market growth benefits the generic makers
Recognizing Critical Gaps in Today's Supply Chain for Temperature-Sensitive Drugs
The potential of translational research for new medicines
The proposed federal National Center for Advancing Translational Sciences holds promise for drug development
FDA offers draft guidance on unsolicited requests for off-label drug information
The basic principle is: say as little as possible in public—and document what is said privately
FDA achieves part of its 'class wide' REMS for immediate-release fentanyl
Manufacturers will share a common access program
Marken formally opens new clinical-distribution service depot in Buenos Aires
Plans to continue expanding in Europe, Asia and Americas
iMany offers Medicare Part D module for its contract-administration software suite
‘Pay and chase’ provisions require manufacturers to pay claims first, then reconcile disputes over charges
FDA approval and inspection process mostly protected American patients from allegedly defective French breast implants
A ‘media frenzy’ is ramping up in France and other countries over health authorities’ call for remedial action; meanwhile, US Congress looks at increased review of medical devices
CMS issues Sunshine Act
Proposed rules are sure to generate intense industry feedback
More actions by GPhA and Obama Administration to address drug shortages
GPhA proposes a central data clearinghouse on drug supplies; will wholesalers participate?
Hospital supply chain participants are gradually taking up GS1 'sunrise' standards
December 2010 and December 2012 dates for adopting GLN and GTIN codes mark steady, if slow, progress
Cold Chain Technologies extends ambient-temperature packaging line
Offers alternative to thermal blankets
ValueCentric and Walgreens sign agreement to make store-level data available to manufacturers
New channel data access could overcome the problem of ‘blinded’ pharmaceutical sales data
UPS Healthcare Logistics adds to network with an Italian acquisition
Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012
Gartner 2011 Healthcare Supply Chain Top 25 puts Cardinal Health at No. 1
Analysis combines financial and operational performance, and industry reputation, among manufacturers, distributors and healthcare systems
Ameritox proposes ongoing monitoring for pain patients, with a validated comparative database
Latest study validates an observational database as a measure across disparate geographies
Specialty drugs are generating a new paradigm: Commercial Innovation
Specialty drug market success requires patient-focused and therapy-specific channel and services strategies
GHX updates progress on a prototype data exchange for track-and-trace
E-commerce hub is soliciting more pharma participants to evaluate data-exchange protocols
PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons ‘lure consumers to switch from generics to expensive brands’
